These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1538303)

  • 1. Pharmacokinetics of lorazepam in critically ill neonates with seizures.
    McDermott CA; Kowalczyk AL; Schnitzler ER; Mangurten HH; Rodvold KA; Metrick S
    J Pediatr; 1992 Mar; 120(3):479-83. PubMed ID: 1538303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study on Intranasal Versus Intravenous Lorazepam in the Management of Acute Seizure in Children.
    Rudra N; Ghosh T; Roy UK
    Folia Med (Plovdiv); 2021 Dec; 63(6):958-964. PubMed ID: 35851245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonus associated with lorazepam therapy in very-low-birth-weight infants.
    Lee DS; Wong HA; Knoppert DC
    Biol Neonate; 1994; 66(6):311-5. PubMed ID: 7727612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions.
    Muchohi SN; Obiero K; Newton CR; Ogutu BR; Edwards G; Kokwaro GO
    Br J Clin Pharmacol; 2008 Jan; 65(1):12-21. PubMed ID: 17635501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam in the treatment of refractory neonatal seizures. A pilot study.
    Deshmukh A; Wittert W; Schnitzler E; Mangurten HH
    Am J Dis Child; 1986 Oct; 140(10):1042-4. PubMed ID: 3752014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children.
    Qureshi A; Wassmer E; Davies P; Berry K; Whitehouse WP
    Seizure; 2002 Apr; 11(3):141-4. PubMed ID: 12018955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam.
    Noerr B
    Neonatal Netw; 2000 Dec; 19(8):65-7. PubMed ID: 11949276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorazepam fast-dissolving drug formulation (FDDF) and intravenous administrations as anaesthetic premedicants: a pharmacokinetic analysis.
    Camu F; Maes V; Van de Velde A; Sevens C
    Eur J Anaesthesiol; 1988 Jul; 5(4):261-8. PubMed ID: 3197710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study.
    Arya R; Gulati S; Kabra M; Sahu JK; Kalra V
    Epilepsia; 2011 Apr; 52(4):788-93. PubMed ID: 21275979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
    Herman RJ; Van Pham JD; Szakacs CB
    Clin Pharmacol Ther; 1989 Jul; 46(1):18-25. PubMed ID: 2743706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lorazepam toxicity in a premature infant.
    Reiter PD; Stiles AD
    Ann Pharmacother; 1993 Jun; 27(6):727-9. PubMed ID: 8329793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
    Gal P; Oles KS; Gilman JT; Weaver R
    Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal from lorazepam in critically ill children.
    Dominguez KD; Crowley MR; Coleman DM; Katz RW; Wilkins DG; Kelly HW
    Ann Pharmacother; 2006 Jun; 40(6):1035-9. PubMed ID: 16720707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorazepam pharmacodynamics and pharmacokinetics in children.
    Relling MV; Mulhern RK; Dodge RK; Johnson D; Pieper JA; Rivera GK; Evans WE
    J Pediatr; 1989 Apr; 114(4 Pt 1):641-6. PubMed ID: 2926577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials.
    Brigo F; Bragazzi NL; Bacigaluppi S; Nardone R; Trinka E
    Epilepsy Behav; 2016 Nov; 64(Pt A):29-36. PubMed ID: 27732915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best BETs from the Manchester Royal Infirmary. BET 1: intranasal lorazepam is an acceptable alternative to intravenous lorazepam in the control of acute seizures in children.
    Allan A; Cullen J
    Emerg Med J; 2013 Sep; 30(9):768-9. PubMed ID: 23943640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.
    Herman RJ; Chaudhary A; Szakacs CB; Woo D; Lane R; Boctor MA
    Eur J Clin Pharmacol; 1995; 48(3-4):253-8. PubMed ID: 7589050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorazepam for the prevention of recurrent seizures related to alcohol.
    D'Onofrio G; Rathlev NK; Ulrich AS; Fish SS; Freedland ES
    N Engl J Med; 1999 Mar; 340(12):915-9. PubMed ID: 10094637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures.
    Al Za'abi M; Lanner A; Xiaonian X; Donovan T; Charles B
    Ther Drug Monit; 2006 Dec; 28(6):793-9. PubMed ID: 17164696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.